The mutation was found in 6 (0.7%) of 877 familial, mostly Caucasian, non-BRCA1/2 breast cancer cases, while the frequency in controls was 0.1% (OR = 5.7, 95% CI = 1.0–40.7, P = 0.02). This evidence concerns the gene BRCA1 and breast carcinoma.